Pill Identifier App

Clinical Trials Update: June 11, 2008

-- Here are the latest clinical trials, courtesy of CenterWatch:

Multiple Sclerosis

If you have a relapsing form of MS, screening EDSS score below 6.0, at least one clinical relapse in the 12 months before screening, and have failed prior treatment with beta-interferon, you may qualify for this study.

The research site is in Nashville, Tenn.

More information

Please see http://www.centerwatch.com/patient/studies/cat102.html.


Rhinitis, Allergic, Perennial

If you have a history of seasonal allergic rhinitis symptoms and a positive skin test of at least one grass allergen, you may qualify for this study. Women of childbearing potential must use a medically acceptable form of contraception.

The research site is in Orange, Calif.

More information

Please see http://www.centerwatch.com/patient/studies/cat804.html.



If you are at least 18, and are able to provide at least four urine samples in a two-week period -- at least one of which is positive for methamphetamine -- you may qualify for this study.

The research site is in Lake Charles, La.

More information

Please see http://www.centerwatch.com/patient/studies/cat219.html.


Copyright 2008 CenterWatch. All rights reserved.

Posted: June 2008

Recommended for you

View comments